Association Between the Initiation of Anti�Tumor Necrosis Factor Therapy and the Risk of Herpes Zoster

• Autores: Kevin L Winthrop, Lang Yao Chen, John W. Baddley, Liyan Liu
• Localización: JAMA: the journal of the American Medical Association, ISSN 0098-7484, Vol. 309, Nº. 9, 2013, págs. 887-895
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Herpes zoster reactivation disproportionately affects patients with rheumatoid arthritis (RA). It is unclear whether anti�tumor necrosis factor (anti-TNF) therapy elevates herpes zoster risk.